Immupharma PLC Annual Financial Report (8691H)

TIDMIMM

RNS Number : 8691H

Immupharma PLC

23 May 2014

FOR IMMEDIATE RELEASE 23 May 2014

Annual Report and Accounts

Notice of Annual General Meeting: 27 June 2014

ImmuPharma PLC (AIM:IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 will be posted to shareholders today.

The Annual Report is available, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Friday 27 June 2014 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

For further information please contact:

ImmuPharma PLC

   Richard Warr, Chairman                                                +44 20 7152 4080 
   Dimitri Dimitriou, Chief Executive Officer                     +44 20 7152 4080 
   Lisa Baderoon, Head of Investor Relations                   +44 7721 413 496 
   Panmure Gordon & Co., NOMAD & Broker                    +44 20 7886 2500

Hugh Morgan, Fred Walsh

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSMMGZKVZLGDZM

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024